1-20 of 4906
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Images
Cumulative incidence of relapse-related mortality and nonrelapse-related mo...
Published: 2019
Figure 1. Cumulative incidence of relapse-related mortality and nonrelapse-related mortality in patients with hematologic malignancies treated with allogeneic BMT as part of the BMTSS cohort. More
Images
Indications for blood transfusion in adults with SCD. Blood transfusion is ...
Published: 2019
Figure 1. Indications for blood transfusion in adults with SCD. Blood transfusion is increasingly used as a disease-modifying therapy in a number of acute and chronic complications, the majority of which have low to moderate quality or no evidence base. The highest-quality evidence is from randomi... More
Images
Proposed model for managing SCD in an adult. (A) The traditional single dis...
Published: 2019
Figure 2. Proposed model for managing SCD in an adult. (A) The traditional single disease–focused framework of comorbidity in which comorbid conditions are considered disease pairs, such as SCD and diabetes mellitus, SCD and cardiovascular disease, and SCD and kidney disease. Most clinical practic... More
Images
(A) Baseline. (B) After initial treatment before transplant. (C) After stem...
Published: 2019
Figure 1. (A) Baseline. (B) After initial treatment before transplant. (C) After stem cell transplant. (D) Three years after transplant. More
Images
Management framework for patients receiving oral anticoagulants.
Published: 2019
Figure 1. Management framework for patients receiving oral anticoagulants. More
Images
Approach to management of direct oral anticoagulant–related bleeding.
Published: 2019
Figure 2. Approach to management of direct oral anticoagulant–related bleeding. More
Images
Platelet-dependent VWF activity assays. (A) VWF:RCo includes “traditional” ...
Published: 2019
Figure 1. Platelet-dependent VWF activity assays. (A) VWF:RCo includes “traditional” assays that use ristocetin to induce VWF binding to platelets. (B) VWF:GPIbR includes assays based on ristocetin-induced binding of VWF to recombinant wild-type GPIbα fragments tethered to either latex particles o... More
Images
Relative risk of clinical manifestations of APS for each aPL-S test. Reprin...
Published: 2019
Figure 1 Relative risk of clinical manifestations of APS for each aPL-S test. Reprinted from Otomo et al 39 with permission. More
Images
Multivariate logistic regression analysis for the development cohort and sc...
Published: 2019
Figure 2. Multivariate logistic regression analysis for the development cohort and scoring system. Reprinted from Sciascia et al 40 with permission. More
Images
Average sales price of brentuximab vedotin per dose in the United States.  ...
Published: 2019
Figure 1. Average sales price of brentuximab vedotin per dose in the United States. 1 Average US sales price for brentuximab vedotin dosed 1.2 mg/kg in a 75-kg patient (ie, two 50-mg single-use vials per dose). CPI, Consumer Price Index. More
Images
Incremental cost-effectiveness of BV + AVD compared with ABVD over a range ...
Published: 2019
Figure 2. Incremental cost-effectiveness of BV + AVD compared with ABVD over a range of potential clinical benefit. *Assumes 2-year modified PFS with ABVD of 76.9%. The displayed absolute percentage differences correspond to hazard ratios of 0.4, 0.5, 0.6, 0.7, 0.8, and 0.9. More
Images
Clinical uses of ctDNA in lymphoma. (A) An idealized schematic of the cours...
Published: 2019
Figure 1. Clinical uses of ctDNA in lymphoma. (A) An idealized schematic of the course of a patient through initial diagnosis, treatment, and relapse with lymphoma. ctDNA assessment has potential applications throughout the disease course, including mutational genotyping prior to treatment, molecu... More
Images
Workup of a patient with suspected MDS predisposition syndrome and manageme...
Published: 2019
Figure 1. Workup of a patient with suspected MDS predisposition syndrome and management implications. eADA, erythrocyte adenosine deaminase; HSCT, hematopoietic stem cell transplant; IHC, immunohistochemistry. More
Images
Evaluation of a variant of uncertain clinical significance.
Published: 2019
Figure 2. Evaluation of a variant of uncertain clinical significance. More
Images
Images
Determinants and consequences of clonal evolution after allogeneic hematopo...
Published: 2019
Figure 1. Determinants and consequences of clonal evolution after allogeneic hematopoietic cell transplantation. More
Images
Main mechanisms of leukemia posttransplantation immune evasion and relapse....
Published: 2019
Figure 2. Main mechanisms of leukemia posttransplantation immune evasion and relapse. More
Images
Serial liver function tests in the patient. Note the acute increases in ser...
Published: 2019
Figure 1. Serial liver function tests in the patient. Note the acute increases in serum bilirubin and aspartate aminotransferase (AST) during vaso-occlusive crises. Note: the units for bilirubin on the chart are SI (µmol/L). More
Images
Cross-sectional imaging. CT liver (top) demonstrates hepatomegaly and irreg...
Published: 2019
Figure 2. Cross-sectional imaging. CT liver (top) demonstrates hepatomegaly and irregular liver outline suggesting established chronic liver disease. MRI of the liver (bottom) shows diffuse injury of the intrahepatic bile ducts, indicative of an established cholangiopathy More
Images